0001889676-23-000001.txt : 20230414 0001889676-23-000001.hdr.sgml : 20230414 20230414144940 ACCESSION NUMBER: 0001889676-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230414 DATE AS OF CHANGE: 20230414 EFFECTIVENESS DATE: 20230414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHARM Therapeutics Inc. CENTRAL INDEX KEY: 0001889676 IRS NUMBER: 872792129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-478944 FILM NUMBER: 23820780 BUSINESS ADDRESS: STREET 1: 33 FOLEY STREET CITY: LONDON STATE: X0 ZIP: W1W 7TL BUSINESS PHONE: 447582703655 MAIL ADDRESS: STREET 1: 33 FOLEY STREET CITY: LONDON STATE: X0 ZIP: W1W 7TL D 1 primary_doc.xml X0708 D LIVE 0001889676 CHARM Therapeutics Inc. 7 Pancras Sq London X0 UNITED KINGDOM N1C 4AG 447582703655 DELAWARE None None Corporation true 2021 Lakshyaditya Singh Aithani c/o CHARM Therapeutics 7 Pancras Sq London X0 UNITED KINGDOM N1C 4AG Executive Officer Director Rishi Gupta c/o CHARM Therapeutics 7 Pancras Sq London X0 UNITED KINGDOM N1C 4AG Director Nihal Sinha c/o CHARM Therapeutics 7 Pancras Sq London X0 UNITED KINGDOM N1C 4AG Director Gary Glick c/o CHARM Therapeutics 7 Pancras Sq London X0 UNITED KINGDOM N1C 4AG Director Muzammil Mansuri c/o CHARM Therapeutics 7 Pancras Sq London X0 UNITED KINGDOM N1C 4AG Director Other Decline to Disclose 06b false 2023-04-06 false true false 0 20045588 20045588 0 The Total Offering Amount and the Total Amount Sold includes the conversion of $13,045,589.04 of outstanding convertible securities. false 2 0 0 0 false CHARM Therapeutics Inc. /s/ Laskhyaditya Singh Aithani Laskhyaditya Singh Aithani Chief Executive Officer 2023-04-14